Logo

AltheaDx to offer Biomarker Services on Affymetrix Platform

Apr 15, 2008
NEW YORK (GenomeWeb News) – AltheaDx today announced that it has been named an Affymetrix authorized service provider.
 
The San Diego-based molecular testing services provider said that the deal enables it to offer biomarker discovery and development services based on Affy’s GeneChip microarray platform. It said it would use the genotyping and gene expression platform to identify new biomarkers and analyze gene pathways that are critical to the development and progression of cancer.
 
Terms of the alliance were not disclosed.

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.